EP1026988A4 - Novel fluorescent reporter molecules and their applications including assays for caspases - Google Patents

Novel fluorescent reporter molecules and their applications including assays for caspases

Info

Publication number
EP1026988A4
EP1026988A4 EP98953317A EP98953317A EP1026988A4 EP 1026988 A4 EP1026988 A4 EP 1026988A4 EP 98953317 A EP98953317 A EP 98953317A EP 98953317 A EP98953317 A EP 98953317A EP 1026988 A4 EP1026988 A4 EP 1026988A4
Authority
EP
European Patent Office
Prior art keywords
caspases
applications including
reporter molecules
fluorescent reporter
novel fluorescent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98953317A
Other languages
German (de)
French (fr)
Other versions
EP1026988A1 (en
Inventor
Eckard Weber
Sui Xiong Cai
John F W Keana
John A Drewe
Han-Zhong Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytovia Therapeutics LLC
Original Assignee
Cytovia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytovia Inc filed Critical Cytovia Inc
Publication of EP1026988A1 publication Critical patent/EP1026988A1/en
Publication of EP1026988A4 publication Critical patent/EP1026988A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052—Val-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Electro-optical investigation, e.g. flow cytometers
    • G01N15/1456—Electro-optical investigation, e.g. flow cytometers without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N2015/1006—Investigating individual particles for cytology
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Electro-optical investigation, e.g. flow cytometers
    • G01N2015/1488—Methods for deciding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
EP98953317A 1997-10-10 1998-10-09 Novel fluorescent reporter molecules and their applications including assays for caspases Withdrawn EP1026988A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US33661 1979-04-26
US6158297P 1997-10-10 1997-10-10
US61582P 1997-10-10
US3366198A 1998-03-03 1998-03-03
PCT/US1998/021231 WO1999018856A1 (en) 1997-10-10 1998-10-09 Novel fluorescent reporter molecules and their applications including assays for caspases

Publications (2)

Publication Number Publication Date
EP1026988A1 EP1026988A1 (en) 2000-08-16
EP1026988A4 true EP1026988A4 (en) 2005-03-30

Family

ID=26709974

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98953317A Withdrawn EP1026988A4 (en) 1997-10-10 1998-10-09 Novel fluorescent reporter molecules and their applications including assays for caspases

Country Status (15)

Country Link
EP (1) EP1026988A4 (en)
JP (1) JP2001519368A (en)
KR (1) KR20010031056A (en)
CN (1) CN1281346A (en)
AU (1) AU754634B2 (en)
BR (1) BR9814816A (en)
CA (1) CA2308125A1 (en)
EA (1) EA200000408A1 (en)
HU (1) HUP0100079A2 (en)
IL (1) IL135365A0 (en)
IS (1) IS5414A (en)
NO (1) NO20001322L (en)
NZ (1) NZ503619A (en)
PL (1) PL341661A1 (en)
WO (1) WO1999018856A1 (en)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342611B1 (en) 1997-10-10 2002-01-29 Cytovia, Inc. Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
AU5116099A (en) 1998-07-21 2000-02-14 Sui Xiong Cai Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof
WO2000054049A2 (en) * 1999-03-12 2000-09-14 Evotec Analytical Systems Gmbh Determination of the chemosensitivity via the caspase activity
EP1055929A1 (en) * 1999-05-26 2000-11-29 Tibotec N.V. Means and methods for drug discovery and the phenotypic characterisation of cells
EP1185644A1 (en) * 1999-05-27 2002-03-13 Merck Frosst Canada & Co. Assays for caspase activity using green fluorescent proteins
US6261794B1 (en) 1999-10-14 2001-07-17 Saint Louis University Methods for identifying inhibitors of methionine aminopeptidases
DE60008574T2 (en) 1999-11-05 2009-10-01 Cytovia, Inc., San Diego Substituted 4H-chromenes and analogues as caspase activators and apoptosis inducers and their use
GB9927331D0 (en) 1999-11-18 2000-01-12 Fluorescience Ltd Assay for measuring enzyme activity in vivo
AU2001293372A1 (en) 2000-04-18 2001-10-30 Cytovia, Inc. Substituted 1,4-thiazepine and analogs and their use as activators of caspases
WO2002012545A2 (en) * 2000-08-03 2002-02-14 Cytovia, Inc. Method of identifying immunosuppressive agents
DE10053747C2 (en) * 2000-10-30 2002-10-24 Deutsches Krebsforsch Method for the simultaneous determination of two fluorescence emissions with a single laser flow cytometer
EP1205540A1 (en) 2000-11-10 2002-05-15 Evotec OAI AG Method of measuring cell vitality
WO2002102301A2 (en) 2000-12-07 2002-12-27 Cytovia, Inc. Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof
US6716851B2 (en) 2000-12-12 2004-04-06 Cytovia, Inc. Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators or caspases and inducers of apoptosis and the use thereof
AU2002303123A1 (en) 2001-03-14 2002-09-24 Cytovia, Inc. Multifluoro-substituted chalcones and analogs as activators of caspases and inducers of apoptosis and the use thereof
US6979530B2 (en) 2001-05-21 2005-12-27 Applera Corporation Peptide conjugates and fluorescence detection methods for intracellular caspase assay
US7148030B2 (en) 2002-02-01 2006-12-12 Promega Corporation Bioluminescent protease assay
US7528164B2 (en) 2002-05-16 2009-05-05 Cytovia, Inc. Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
WO2003096982A2 (en) 2002-05-16 2003-11-27 Cytovia, Inc. Substituted 4h-chromenes, 2h-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof
CA2491692C (en) * 2002-07-08 2010-12-07 Amersham Biosciences Uk Limited Reagents and a method for saturation labelling of proteins
AU2003299378A1 (en) * 2002-10-11 2004-05-04 Board Of Regents, The University Of Texas System Method and compounds for inhibiting hec1 activity for the treatment of proliferative diseases
US6821744B2 (en) 2002-10-29 2004-11-23 Roche Diagnostics Operations, Inc. Method, assay, and kit for quantifying HIV protease inhibitors
WO2005003100A2 (en) 2003-07-03 2005-01-13 Myriad Genetics, Inc. 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
WO2005047245A2 (en) 2003-11-14 2005-05-26 Wisconsin Alumni Research Foundation Fluorescence assays with improved blocking groups
EP1704257A2 (en) 2004-01-16 2006-09-27 Applera Corporation Fluorogenic kinase assays and substrates for kinases and phosphatases
US7553632B2 (en) 2004-01-22 2009-06-30 Promega Corporation Luminogenic and nonluminogenic multiplex assay
US7416854B2 (en) 2004-01-22 2008-08-26 Promega Corporation Luminogenic and nonluminogenic multiplex assay
NZ566799A (en) 2005-09-14 2011-04-29 Takeda Pharmaceutical Dipeptidyl peptidase inhibitors for treating diabetes
CN101360723A (en) 2005-09-16 2009-02-04 武田药品工业株式会社 Process for the preparation of pyrimidinedione derivatives
JP5380074B2 (en) * 2005-12-12 2014-01-08 イノーバ・バイオサイエンシズ・リミテッド Complex generation
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8227205B2 (en) 2007-04-13 2012-07-24 Promega Corporation Luminescent live and dead cell assay
KR100909996B1 (en) * 2007-09-19 2009-07-29 한국생명공학연구원 Fusion protein for detecting the activity of caspase-3 and a method for detecting the activity of caspase-3 using the same
CN102603695B (en) * 2012-02-10 2014-06-18 山东大学 Amino acid-fluorophore compound and application thereof
WO2014013272A1 (en) 2012-07-19 2014-01-23 Kingston University Higher Education Corporation Rhodamine based fluorescent probe for coagulase activity and detection of coagulase producing bacterial strains
CN104458709A (en) * 2013-09-12 2015-03-25 中国药科大学 High flux screening method for screening calcium activated neutral protease-1 inhibitor
ES2806134T3 (en) 2014-07-11 2021-02-16 Univ Tokyo Fluorescent probe to detect dipeptidyl peptidase IV
CN104263356B (en) * 2014-09-29 2016-02-24 辽宁大学 A kind of rhodamine pH fluorescent probe and application thereof containing methionine(Met) structure
CN106146611B (en) * 2015-05-14 2019-09-17 中国科学院大连化学物理研究所 It is a kind of measure dipeptidyl peptidase IV activity fluorescence probe substrate and its application
EP3475443A1 (en) 2016-06-23 2019-05-01 Life Technologies Corporation Methods and compositions for detecting or measuring caspases or apoptosis
WO2018071556A1 (en) * 2016-10-11 2018-04-19 The Regents Of The University Of California Detection, identification, and purification of degradative and non-degradative enzymes in biological samples
CN108129388A (en) * 2018-01-08 2018-06-08 深圳市佶达德科技有限公司 A kind of rhodamine double pyrazole acetic acid esters organic laser material and its application
CN107987019A (en) * 2018-01-08 2018-05-04 深圳市佶达德科技有限公司 A kind of preparation method of rhodamine double pyrazole acetic acid esters organic laser material
CN108760234B (en) * 2018-06-05 2020-05-15 哈尔滨工程大学 Method and device for synchronously testing fluid flow and solid motion information based on PIV (particle image velocimetry) and PTV (particle beam velocimetry) technologies
KR102138256B1 (en) * 2018-09-13 2020-08-13 한국과학기술연구원 probe for measuring the activity of caspase-1 and composition for diagnosis of inflammatory diseases comprising the same
CN112961209B (en) * 2021-04-07 2022-06-24 中国科学院武汉病毒研究所 caspase inhibitors and uses thereof
CN114107435A (en) * 2021-11-30 2022-03-01 广东省人民医院 Activatable photoacoustic-fluorescence dual-mode probe for real-time monitoring of immunotherapy and application
CN117143949B (en) * 2023-08-31 2024-04-05 青岛海洋食品营养与健康创新研究院 Euphausia superba source high F value oligopeptide and application thereof in liver protection

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996033209A1 (en) * 1995-04-21 1996-10-24 Merck Frosst Canada Inc. Peptidyl derivatives as inhibitors of pro-apoptotic cysteine proteinases
US5576424A (en) * 1991-08-23 1996-11-19 Molecular Probes, Inc. Haloalkyl derivatives of reporter molecules used to analyze metabolic activity in cells
WO2000004914A1 (en) * 1998-07-21 2000-02-03 Cytovia, Inc. Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4557862A (en) * 1983-10-28 1985-12-10 University Patents, Inc. Rhodamine derivatives as fluorogenic substrates for proteinases
US5587490A (en) * 1990-04-16 1996-12-24 Credit Managers Association Of California Method of inactivation of viral and bacterial blood contaminants
US5556992A (en) * 1994-09-02 1996-09-17 Universite De Montreal Novel rhodamine derivatives for photodynamic therapy of cancer and in vitro purging of the leukemias

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576424A (en) * 1991-08-23 1996-11-19 Molecular Probes, Inc. Haloalkyl derivatives of reporter molecules used to analyze metabolic activity in cells
WO1996033209A1 (en) * 1995-04-21 1996-10-24 Merck Frosst Canada Inc. Peptidyl derivatives as inhibitors of pro-apoptotic cysteine proteinases
WO2000004914A1 (en) * 1998-07-21 2000-02-03 Cytovia, Inc. Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LENDECKEL U ET AL: "Induction of the membrane alanyl aminopeptidase gene and surface expression in human T-cells by mitogenic activation.", THE BIOCHEMICAL JOURNAL. 1 NOV 1996, vol. 319 ( Pt 3), 1 November 1996 (1996-11-01), pages 817 - 821, XP002301554, ISSN: 0264-6021 *
See also references of WO9918856A1 *
TALANIAN R V ET AL: "SUBSTRATE SPECIFICITIES OF CASPASE FAMILY PROTEASES", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 272, no. 15, 11 April 1997 (1997-04-11), pages 9677 - 9682, XP000652322, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
AU754634B2 (en) 2002-11-21
WO1999018856A1 (en) 1999-04-22
EA200000408A1 (en) 2000-12-25
IL135365A0 (en) 2001-05-20
PL341661A1 (en) 2001-04-23
EP1026988A1 (en) 2000-08-16
CA2308125A1 (en) 1999-04-22
NO20001322L (en) 2000-06-13
NZ503619A (en) 2001-11-30
BR9814816A (en) 2004-06-22
HUP0100079A2 (en) 2001-05-28
JP2001519368A (en) 2001-10-23
CN1281346A (en) 2001-01-24
NO20001322D0 (en) 2000-03-14
IS5414A (en) 2000-03-24
KR20010031056A (en) 2001-04-16
AU1072299A (en) 1999-05-03

Similar Documents

Publication Publication Date Title
EP1026988A4 (en) Novel fluorescent reporter molecules and their applications including assays for caspases
DE69520644D1 (en) Fluorescent label composition and label obtained
IL113343A0 (en) CTLA4 molecules and their uses
EP1007949A4 (en) Multiple assays of cell specimens
IL133830A0 (en) Vertebrate tolomerase genes and proteins and uses thereof
FI954133A0 (en) Mixing Mill
IL119644A0 (en) Rapid microbiological assays
AU4363999A (en) Novel photoinitiators and their applications
GB9408344D0 (en) Nucleic acid assays
GB9721961D0 (en) Novel molecules
EP0817817A4 (en) Novel ice-controlling molecules and their applications
GB9715522D0 (en) Assays
AU3977699A (en) Ags proteins and nucleic acid molecules and uses therefor
FR2747686B1 (en) FLUORESCENT MATERIAL
ZA9811354B (en) Novel flea epoxide hydrolase nucleic acid molecules proteins and uses thereof
DE59808032D1 (en) agitating mill
GB9417793D0 (en) Bioluminescence and assay reagents
AUPO470197A0 (en) Fluorescent dyes from microorganisms
EP0721976A3 (en) Fluorescent materials
EP1007682A4 (en) Novel nucleic acid molecules and uses therefor
AU4818299A (en) Novel photoinitiators and applications therefor
GB2289790B (en) Planar lamps and displays
KR100217410B1 (en) Red fluorescent material
AUPO506797A0 (en) Novel molecules and uses thereof
AUPO823397A0 (en) Novel nucleic acid molecules and uses therefor

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000508

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 20000508;LT PAYMENT 20000508;LV PAYMENT 20000508;MK PAYMENT 20000508;RO PAYMENT 20000508;SI PAYMENT 20000508

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ZHANG, HAN-ZHONG

Inventor name: DREWE, JOHN, A.

Inventor name: KEANA, JOHN, F., W.

Inventor name: CAI, SUI, XIONG

Inventor name: WEBER, ECKARD

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12Q 1/37 B

Ipc: 7G 01N 33/58 B

Ipc: 7C 12P 17/06 B

Ipc: 7G 01N 33/574 B

Ipc: 7G 01N 33/48 B

Ipc: 7C 12Q 1/70 B

Ipc: 7C 12Q 1/00 B

Ipc: 7A 61B 8/00 A

A4 Supplementary search report drawn up and despatched

Effective date: 20050215

17Q First examination report despatched

Effective date: 20070320

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ZHANG, HAN-ZHONG

Inventor name: DREWE, JOHN, A.

Inventor name: KEANA, JOHN, F., W.

Inventor name: CAI, SUI, XIONG

Inventor name: WEBER, ECKARD

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RTI1 Title (correction)

Free format text: FLUORESCENT REPORTER MOLECULES AND THEIR APPLICATIONS INCLUDING ASSAYS FOR CASPASES

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20081029